PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.86%
Negative 5Y CAGR while JHX stands at 60.19%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-21.14%
Negative 3Y CAGR while JHX stands at 28.96%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
15.37%
Below 50% of JHX's 112.88%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-15.90%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
454.81%
5Y net income/share CAGR above 1.5x JHX's 17.50%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
41.58%
Positive short-term CAGR while JHX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
45.94%
Positive 5Y equity/share CAGR while JHX is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
22.63%
Positive short-term equity growth while JHX is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
61.56%
5Y dividend/share CAGR at 50-75% of JHX's 108.10%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
8.38%
Below 50% of JHX's 36.25%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.